A patient presenting with severe malaria, with hyperparasitaemia, received 7-day artesunate monotherapy. A severe recrudescence was detected and attributed to hyperparasitaemia, monotherapy and a polyclonal infection without Kelch 13 gene mutation. A second treatment with artesunate, then quinine, followed by artemether-lumefantrine, was successful.
All Keywords
【저자키워드】 resistance, artesunate, severe malaria, K13, Parasite clearance time,
【저자키워드】 resistance, artesunate, severe malaria, K13, Parasite clearance time,